Endocrinology Flashcards
What is acromegaly?
- Excess growth hormone, normally secondary to pituitary adenoma
- Spade like hands and feet, large tongue, excessive sweating, raised prolactin, protruding jaw
- Sometimes features of pituitary tumour: headaches, bitemporal haemianopia
Investigations of acromegaly?
- IGF1 levels initially then OGTT as gold standard (GH will not be suppressed)
- Pituitary MRI
Management of acromegaly?
- Trans-sphenoidal surgery
- Somatostatin analogues which inhibit GH release e.g Octreotide
- Pegvisomant which is GH receptor antagonist
- Dopamine agonists e.g. bromocriptine
What is Addisons disease?
- Autoimmune destruction of darnel glands causing primary hypoadrenalism
- Reduced cortisol and aldosterone
- Lethargy, anorexia, weight loss, hyperpigmentation, ‘salt craving’
- Hyponatraemia and Hyperkalaemia
Other causes of hypoadrenalism?
- TB
- Metastases
- HIV
- Antiphospholipid
How to tell difference between primary Addisons and secondary adrenal insufficiency?
- Hyperpigmentation is only in primary Addisons
Investigations for Addisons
- 9am serum cortisol
- Synacthen test (gold standard): cortisol levels will not increase adequately
Management of Addisons
- Replacement glucocorticoid (cortisol): hydrocortisone
- Replacement mineralocorticoid (aldosterone): fludrocorticoid
- Doses given to mirror cycle of release in body
- Patient education around illness and symptoms of adrenal crisis
Addisonian crisis
- Causes by sepsis, surgery, haemorrhage or steroid withdrawal
- Hypotension, shock, delirium, abdo pain, vomiting, headaches, fever
- Managed with IM/IV Hydrocortisone, IV fluids
What is Bartter’s syndrome?
- Inherited cause of severe hypokalaemia due to defective chloride absorption at the loop of Henle
- Presents with failure to thrive in childhood/diabetes like symptoms
Corticosteroid Groups
- Mineralocorticoid: Fludrocortisone
- Glucocorticoid: Hydrocortisone, Dexamethasone, Betamethasone
Steroids side effects
- Impaired glucose regulation
- Increased appetitie/weight gain
- Hirsutism
- Hyperlipidaemia
- Cushings syndrome (moon face, buffalo hump)
Steroids management
- Doses should be doubled in intercurrent illness for those on long-term steroids
- Should not be withdrawn abruptly: Addisionian crisis
Cushings disease
- Pituitary adenoma secreting excessive ACTH which stimulates excessive cortisol from the adrenals
Causes of Cushings syndrome (high levels of glucocorticoids in the body)
- Cushings disease
- Adrenal adenoma (excess cortisol)
- Paraneoplastic syndrome
- Exogenous steroid use
Cushings syndrome presentation
- Moon face
- Central obesity
- Abdominal striae
- Buffalo hump
- Hirsutism
- Hyperpigmentation of skin in Cushings disease
Conditions associated with Cushings
- HTN
- T2DM
- Osteoporosis
- Dyslipidaemia
What sign helps to distinguish cushings diseases as a cause compared to steroids/adrenal adenoma?
Hyperpigmentation of skin (ACTH stimulates melanin production)
Management of Cushings
- High dose dexamethasone supression test
- Removal of pituitary/adrenal tumour
- Adrenalectomy plus lifelong steroid replacement
T1DM
- Pancreas stops producing adequate insulin
- Hyperglycaemia: polyuria, polydipsia, weight loss
Insulin production
- Beta cells in islets of langerhans in pancreas -> causes absorption of glucose by cells and promotes glycogenesis where glucose is stored as glycogen in liver
DKA Triad
- Ketoacidosis
- Dehydration
- Potassium imbalance
Presentation of DKA
- Polyuria
- Polydipsia
- N+V
- Sweet smelling breath
- Dehydration
- Weight loss
Treatment of DKA
- IV Fluids
- Insulin
- Glucose
- Potassium
- Infection
- Chart fluids
- Ketone monitoring
Long term management of T1DM
- Insulin via basal bolus (1 long acting and then short-acting before meals0
- Monitor blood sugar and complications
Hypoglycaemia
- Hunger
- Tremors
- Sweating
- Irritability
- Dizziness
- Pallor
- Tx with rapid acting glucose followed by slower acting carbohydrates
T2DM
- Fasting glucose >7
- Random glucose >11.1
- HBA1c > 48
T2DM Treatment
- Metformin
- SGLT-2 inhibitor e.g empagliflozin for patients with high risk of CVD
- DPP-4 inhibitor e.g. Sitagliptin
- Sulfonylurea e.g. Gliclazide
- Insulin
Metformin pharmacology
- increases insulin sensitivity/decreases glucose production
- Does not cause weight gain/hypoglycaemia
- S/E include GI symptoms and lactic acidosis
SGLT-2 Inhibitors pharmacology
- Blocks reabsorption of glucose from urine into blood causing it to be excreted
- Cause cause hypoglycaemia when used with sulfonylurea/insulin
- S/E include urinary frequency/urgency, thrush, weight loss, DKA